News Hub | News Direct

Technology

Artificial Intelligence Big Data Cloud Computing Cyber Security Data Management Electronics Enterprise & Network Technology Financial Technology Hardware Mobile & Wireless Nanotechnology Semiconductor Software Telecommunications
Article thumbnail News Release

VTS Recognized on Commercial Observer’s Annual Power Proptech List For Second Consecutive Year

VTS

VTS, the commercial real estate industry’s only technology platform that unifies owners, operators, brokers, and tenants to capitalize on opportunities revealed in every square foot of their properties, today announced that Commercial Observer has recognized CEO Nick Romito and Chief Technology Officer Swaroopa Penikelapati in it’s second annual Power Proptech List. This is Romito’s second year being featured on the list and the first for Penikelapati. “For over a decade, VTS has been at the forefront of the Proptech space, pioneering innovative solutions that have transformed how the real estate industry operates and providing our customers with technologies to improve the way they operate and do business. It’s an honor to be featured in Commercial Observer’s Power Proptech list for the second year in a row alongside other prominent executives who are driving innovation in real estate,” said Romito. “We see this recognition as a testament to our influence in the industry and are excited to continue scaling as we head into 2024.” Under Romito and Penikelapati’s leadership, VTS has continued to set the bar for innovation within the commercial real estate industry and has been a driving force in the company’s growth over the past year. Following the acquisitions of Rise Buildings and Lane Technologies in 2021 and a CBRE-led Series E fundraise in 2022, VTS announced the launch of VTS Activate, the company’s revolutionary tenant experience platform that enables CRE owners and operators to create a fully integrated office experience, in May of this year. VTS continues to be a trusted source for industry data, with its quarterly VTS Office Demand Index (VODI) and annual Global Landlord Report. The company has also made strategic additions to its leadership team to meet growing demand and platform expansion through the appointments of Sachin Shah as its first Chief Customer Officer in August and Penikelapati as Chief Technology Officer in November 2022. "I’m thrilled to be included in the Commercial Observer Power Proptech List following my appointment as VTS’ Chief Technology Officer last year,” said Penikelapati. “As a minority woman in a male-dominated industry like real estate, I’m proud to be represented on this list through contributing to meaningful outcomes for our customer base and the industry at large. I look forward to continuing to push the boundaries of what our platform can deliver.” Commercial Observer’s annual Power Proptech List is a compilation of the most influential individuals in the rapidly evolving world of Proptech. In a field that continues to undergo significant transformation, this list recognizes executives and companies that shape the industry and possess the resilience and innovation necessary to thrive in changing times. VTS is the commercial real estate industry’s only technology company that unifies owners, operators, brokers, and tenants in a single platform to capitalize on opportunities revealed in every square foot of their properties. In 2013, VTS revolutionized the commercial real estate industry’s leasing operations with what is now VTS Lease. Today, the VTS Platform is the largest first-party data source in the industry, transforming how strategic decisions are made and executed by CRE professionals across the globe. With the VTS Platform, consisting of VTS Lease, VTS Activate, VTS Data, and VTS Market, every business stakeholder in commercial real estate is given real-time market information and workflow tools to do their job with unparalleled speed and intelligence. VTS is the global leader, with more than 60% of Class A office space in the U.S., and 12 billion square feet of office, retail, and industrial space is managed through our platform worldwide. VTS’ user base includes over 45,000 CRE professionals and industry-leading customers such as Blackstone, Brookfield Properties, LaSalle Investment Management, Hines, BXP, Oxford Properties, JLL, and CBRE. To learn more about VTS, and to see our open roles, visit www.vts.com. Contact Details Marino PR Sofia Chevez +1 646-912-5354 schevez@marinopr.com Company Website https://www.vts.com/

October 16, 2023 11:00 AM Eastern Daylight Time

Article thumbnail News Release

AI startup Leucine nets $7M to level up Pharma manufacturing compliance to keep pace with drug innovation

Leucine

Pharmaceutical manufacturing is the lynchpin to getting drug innovation to people. While compliance protocols are key to ensuring the smooth operation of the industry, they are beset by processes that are not fit for purpose and are hindering their ability to deliver life-saving drugs faster. Suffocated by paper-based records and legacy systems, the large-scale manufacturing of drugs is being hampered. It’s little wonder that a staggering 2 out of 3 FDA warnings are for non-compliance related to procedures not being followed appropriately, unclear work instructions of methods, failure to review equipment usage logs, and lack of shared procedures between Quality Assurance and production departments. These matters are often missed and go unnoticed because of the conventional paper-based systems in the pharmaceutical industry. Helping to make pharmaceutical manufacturing compliant, safer, and faster, tech startup Leucine is today announcing a $7M series A funding round led by Ecolab Inc., a strategic investor, to scale its Compliance Cloud platform globally. This round also saw participation from all existing investors, including Pravega Ventures, Axilor Ventures, Techstars, and angels. Vivek Gera, founder, and CEO of Leucine, commented: “Paper-based manufacturing records are the industry's achilles' heel, fueling not only regulatory nightmares but also ballooning production costs and inefficiencies. The legacy solutions are no better, with their extremely long implementation cycles and rigid, siloed applications that leave manufacturers in a lurch.” Leucine's Compliance Cloud serves as a digital twin of the pharma manufacturing shop floor, bringing real-time performance monitoring, compliance management, and actionable insights to the table. For pharma manufacturers, leveraging data can mean the difference between a successful batch and a costly recall. What differentiates Leucine from some of the legacy digitization tools is its AI-driven capabilities designed not only to digitize pharma manufacturing workflows faster but also to provide proactive insights that enable pharma companies to stay compliant and produce faster and in a cost-effective manner. Leucine's platform can be implemented in 8 weeks. This speed of implementation becomes possible because of the proprietary AI-enabled digital process builder based on Large Language Models (LLMs) that rapidly digitizes paper SOPs into execution-ready digital formats. "Our models are trained on a wealth of pharma data, which allows the platform to create custom workflows enriched with GxP compliance measures, enabling us to deliver unparalleled value at breakneck speed," added Vivek Gera. A batch execution procedure is the single most important document in pharma manufacturing. This rapid digitization capability reduces the digitization cycle of a batch record from 6-8 months to 3-5 days. Leucine is currently deployed at over 30 companies in over 300 pharma manufacturing facilities across 10 countries, including the US, India, Brazil, Mexico, UAE, and others. The company is today also announcing the beta launch of Leucine10x, a groundbreaking AI framework designed to serve as a co-pilot in pharmaceutical manufacturing processes. Leucine10x will revolutionize how decision-making is done in pharma manufacturing, enabling Production and Quality Assurance teams to achieve their organization goals with ease and confidence. Built on proprietary LLM technology, Leucine10x offers an army of AI co-pilots that perform highly specialized tasks such as digitizing paper-based SOPs, creating a digital twin of the shop floor, collaborating with Production Managers in creating dynamic production plans, thus ensuring on-time batch delivery. Most significant is their ability to speed up Root Cause Analysis (RCA) of deviations in the manufacturing process by quickly analyzing data, including text-based records, logs, and even staff interview transcripts, to identify potential issues or patterns that might not be readily apparent. Mustaq Singh Bijral, Co-founder and CPO of Leucine, said: "We're excited to share that Leucine10x is already operational in select customer facilities under a trusted tester agreement. The response has been incredibly positive, and due to high demand, we're currently enrolling new customers through a waitlist". The funding round will support Leucine in refining its AI capabilities and making its AI Co-pilot a trusted partner to the production and quality managers on the shop floor and in expanding its reach to more facilities and customers. “Vivek and Mustaq have been relentless in their mission to make pharma manufacturing safer. This latest funding round will enable Leucine to bring the power of LLMs and associated technologies to make significant advances in pharma manufacturing. We couldn’t be happier to support them in this quest” said Rohit Jain, Co-founder and Partner at Pravega Ventures. Pravega Ventures also invested in the Seed round of Leucine. Vivek Gera remarked: "We're just scratching the surface; our vision is to leverage AI and technology to bring safe medicine to patients across the world” About Leucine Leucine is at the forefront of digitizing pharmaceutical manufacturing, leveraging cutting-edge AI technologies to bring unprecedented efficiency and compliance to the shop floor. Our innovative solutions, from Batch Planning to Batch Release, aim to modernize traditional procedures, replacing paper-based records with a seamless, digital-first approach. Trusted by industry leaders, Leucine not only streamlines the manufacturing process but also delivers actionable insights through its AI-driven analytics dashboard, empowering pharma companies to produce safer and more effective medicines. Leucine is headquartered in New Jersey, United States. For more information, visit https://www.leucine.io/ About Pravega Ventures Pravega Ventures is an early stage Venture Capital fund that partners with passionate founders, who are leveraging technology to either disrupt existing markets or create new ones. Contact Details Leucine Sampada Bhootna +91 81458 07848 sampada.bhootna@leucinetech.com Company Website https://www.leucine.io/

October 16, 2023 09:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

GaleForceMedia Introduces AI-Assisted Media Buying & Planning

GaleForce Digital Technologies

Gale Force Digital Technologies has announced the development of a patent-pending AI technology for its media buying and planning platform, Gale Force Media. “We are thrilled to launch this new technology,” said Jen Williams, Vice President of Product Development at Gale Force. “This significant step forward represents our unwavering commitment to delivering cutting-edge solutions that empower our clients to achieve unprecedented success in the ever-evolving landscape of media advertising.” The new AI technology assists advertisers and agencies in determining effective media mixes by providing real-time recommendations based on a multitude of data points. The AI analyzes patterns, trends, and insights in local and national markets using internal and external databases to generate the most ideal options for media placements. Once the AI presents the results, Gale Force Media users have the flexibility to modify or accept the proposed media buy. Furthermore, the new technology will be able to parse much larger datasets than its human counterparts, allowing pattern recognition and planning on a scale previously unattainable. It is also capable of suggesting budget allocations, ad content type, content duration, and target KPIs per media channel. GaleForce's AI is built to continuously learn and improve based on data-driven assessments of its recommendations. About Gale Force Digital Technologies Headquartered in West Palm Beach, Florida, Gale Force Digital Technologies has been providing advanced media planning software, digital marketing tools, and other solutions since 2014. The products offered are GaleForceMedia, a media planning and buying tool; LocalForce, a local search management solution; ClickForce, a paid search advertising platform; SocialForce, a multi-platform management software for managing social profiles and scheduling posts; AdForce, a programmatic digital media buying solution; and ReForce, a proprietary review generation and reputation management platform. GaleForce is continually crafting and refining products to better serve its ever-growing client base. Contact Details Gale Force PR Department +1 866-233-8499 pr@galeforcedigital.com Company Website https://galeforcedigital.com/?utm_source=news_direct&utm_medium=pr&utm_campaign=gail

October 16, 2023 08:15 AM Eastern Daylight Time

Article thumbnail News Release

IQGeo Group anticipating "much higher growth in software revenues"

IQGeo Group PLC

IQGeo Group PLC (AIM:IQG) chief executive Richard Petti and chief financial officer Haywood Chapman speak to Thomas Warner from Proactive after releasing the software developer's half-year report for the six months to 30 June 2023. Petti starts by addressing the Group's acquisition of fewer new clients compared to previous years, highlighting that the company's revenues surged by 123% to over £20mln, with 83% of that increase attributed to organic growth. Petti highlighted the success of their "land and expand" strategy, emphasising long-term relationships and continuous upselling to existing customers. Chapman confirms the successful integration of recent acquisition Comsof NV, which has enabled them to secure a significant contract with a tier-one national utility provider in southern Europe, valued at €8.6mln over six years. Petti also introduced their new "editions strategy" this summer, aiming to cater to the diverse needs of their customer base, ranging from global telcos to private network operators. This strategy offers three editions of their product, ensuring each customer type receives an experience tailored to their requirements. Addressing growth predictions, Chapman acknowledges a market forecast of 8% growth for the next year but emphasises a shift in their strategy that will focus on higher-margin software revenues, potentially leading to a 48% growth in their adjusted EBITDA. The duo remains optimistic about IQGeo's competitive edge and future growth prospects. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

October 16, 2023 07:56 AM Eastern Daylight Time

Video
Article thumbnail News Release

SSV Capital NED reveals high hopes ahead of SmartPay soft launch

SSV Capital Ltd

SSV Capital Non-Executive Director David Lewis visits the Proactive London studio to speak with Thomas Warner about the emerging company's core mission and pillars. SSV Capital is a portfolio company with an underlying ESG (Environmental, Social, and Governance) focus that emphasises the intertwined importance of people, planet, and prosperity. The firm operates on three main pillars: a FinTech initiative named SmartPay, a commercial property division focusing on eco-friendly solutions, and a fund exclusively centred on ESG investments. Lewis, who brings experience in digital transformation, highlights the company's commitment to investing in organisations with similar ESG goals. He expresses excitement about SmartPay's upcoming soft launch, which utilizes QR codes and open banking standards to reduce costs and environmental impact. Lewis explains that his decision to join SSV Capital was influenced by the company's dedication to addressing climatic challenges and its talented executive team. He says "As a planet we're in an existential crisis, and in that context it is obligatory for those of us who... understand the crisis to engage with it." Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

October 16, 2023 06:27 AM Eastern Daylight Time

Video
Article thumbnail News Release

Tribe Property Technologies round out management team announcing Angelo Bartolini as CFO

Tribe Property Technologies Inc.

Tribe Property Technologies CEO Joseph Nakhla and new company chief financial officer Angelo Bartolini joined Steve Darling from Proactive to provide some key updates on the company. Bartolini, with over 12 years of experience in a public company setting, has taken on the role of CFO at Tribe Property Technologies. His most recent position was as CFO of Altus Group, where he played a crucial role in driving transformative growth for the company. In his new role at Tribe, Bartolini will leverage his expertise in capital management, equity and debt financing, and performance management including budgeting and forecasting, financial risk management, and M&A execution and integration. Bartolini shared his perspective on why he chose to join Tribe and how he plans to leverage his experience to contribute to the company's progress. Additionally, Joseph Nakhla announced that Tribe Property Technologies has signed a definitive loan agreement with the Technology and Innovation Banking arm of a Canadian bank, securing up to $15 million. This facility comprises a $3 million operating line to support the company's working capital requirements and an M&A facility of $7 million, with an additional $5 million allocated for future use. This financing agreement reflects the company's strategic approach to financial management and its commitment to supporting its growth initiatives. In summary, Tribe Property Technologies has strengthened its leadership team with the appointment of Angelo Bartolini as CFO, adding significant financial expertise to the company. The financing agreement further positions Tribe for growth and expansion as it continues to provide innovative solutions in the property management sector. Contact Details Proactive Investors Canada +1 604-688-8158 na-editorial@proactiveinvestors.com

October 13, 2023 02:20 PM Eastern Daylight Time

Video
Article thumbnail News Release

New Play-to-Earn Meme Coin NuggetRush Launches Presale - Next 10x Crypto?

RoundHouse Media

TL;DR - NuggetRush (NUGX) is a groundbreaking protocol that bridges the gap between gaming and the crypto universe. - It is a highly immersive P2E game where players can earn NUGX rewards while having a lovely time in arguably one of the best games with thrilling storylines in 2023. - The NUGX presale launch has ignited frenzy from meme coin fans and astute investors who have identified an once-in-a-lifetime opportunity. - Supporters are convinced that NUGX is an undervalued gem that will easily become a 10X sensation, outperforming top coins like Cardano (ADA). NuggetRush (NUGX) is currently showing the broader crypto world and the gaming scene what it means to understand and solve problems facing users. The platform is releasing novel concepts that have thus far captured the imagination of investors and enthusiasts alike. As of October 2023, NuggetRush is undoubtedly one of the best coins to invest in, a crypto star that promises to change how serious investors perceive meme coins and reshape the entire multi-billion play-to-earn gaming industry. So, what is driving NuggetRush, and why do investors want NUGX to be one of the top crypto coins in the coming months, surging by more than 10X on launch? Visit NuggetRush Presale NuggetRush: A Play-to-Earn Marvel Merging Gaming Meets Crypto NuggetRush (NUGX) is a groundbreaking protocol that has finally succeeded in bridging the gap between gaming and the fast-moving and demanding crypto universe. The platform offers a highly immersive P2E game where players can earn NUGX rewards while having a lovely time in arguably one of the best games with thrilling storylines in 2023. NuggetRush is launching on Ethereum (a proven blockchain) and utilizing its time-tested and secure smart contracts so that players can easily monetize their gaming skills, effectively turning their passion into money in a secure environment. Visit NuggetRush Presale NUGX Presale Buzz: The Next 10x Crypto? For what lies ahead, the NUGX presale launch has ignited a frenzy from meme coin fans and astute investors who have identified a once-in-a-lifetime opportunity. Supporters are convinced that NUGX is an undervalued gem that will easily become a 10X sensation, outperforming top coins like Cardano (ADA). Because of this expected growth, many say NuggetRush could revive the highly depressed gaming and NFTs scene in 2023, even triggering a bull run once the project launches. As of mid-October, there has been a noticeable spike in NuggetRush-related searches in top search engines like Google and Bing. This could mean that early adopters and some of crypto's top investors view NUGX as a golden opportunity to get exposure in a well-thought-out project that seamlessly blends entertainment, crypto, and finance. As history reveals, the presale phase of quality protocols can offer exclusive benefits for early investors who stand to become "whales" and influencers as the project matures and delivers its vision-mission statement. Accordingly, those positioning themselves in NUGX in what will easily be a top ICO-- if past performance of other crypto success repeats--stand to reap big profits as the ERC-20 coin surges to even register more than 10X gains. Visit NuggetRush Presale Looking Ahead: Navigating the NuggetRush Journey NuggetRush has an edge that's increasingly hard to find in crypto: it places the community at the core of its development journey. The protocol's creators understand the significance of fostering a dedicated and passionate user base to propel its growth. Through collaborative decision-making, where NUGX holders play a crucial role, the community determines the project's direction. Already, NuggetRush developers have revealed that they will renounce their smart contracts, giving control to holders. This inclusive approach enhances transparency and ensures that the project resonates with the audience it aims to serve. The NUGX presale is already bringing a sense of excitement and anticipation. The fusion of gaming, crypto, and community engagement has laid the foundation for what could easily be a game-changing platform. Factoring the deflationary nature of the token and the structure of the presale that's set to massively benefit early adopters, there could be an opportunity for early birds to scoop NUGX, which is available at a discount, as they await for more than 10X their investment. Visit NuggetRush Presale Contact Details NuggetRush Team media@nuggetrush.io

October 13, 2023 09:30 AM Eastern Daylight Time

Article thumbnail News Release

How Safe Is A Gold Investment In 2024?

Benzinga

By Faith Ashmore, Benzinga The past few years have been marked by high inflation and unstable markets. As we go into an election year – which is an economic environment known to be notoriously volatile – it's important to once again revisit what type of investments are relatively safe from market turbulence. Historically, commodities and metals have always been investors’ preferred stores of value because they help hedge against inflation. But the question remains: as the world becomes more digitized and currencies like Bitcoin take off, are commodities like gold still a worthwhile investment? According to many respected experts, the answer is yes. Gold has consistently proven itself a reliable investment option, especially during uncertain times. One such example was seen in 2020 when the global pandemic led to market pessimism and caused the price of gold to reach a historic high of $2,074 per ounce. Similarly, in 2022, Russia's invasion of Ukraine in late February drove the yellow metal's value above $2,000 once again. Following the pandemic, the gold market narrative has primarily revolved around two contrasting factors: persistently high inflation and the actions of central banks, with particular emphasis on the U.S. Federal Reserve. Central banks, like the Fed, have been raising interest rates in response to soaring consumer prices. While no investment is truly safe, this dynamic has further solidified gold's reputation as a safer investment choice for those seeking stability in uncertain economic environments. Gold has historically been considered a hedge against inflation, as it tends to retain its value or even appreciate during periods of rising prices. Analysts at UK-based Standard Chartered shared that they expect “to see gold as a core holding and a key portfolio diversifier… we expect the physical market to pick up the baton from here as we enter the seasonally strong period for consumption. The recent escalation of the Russia-Ukraine conflict is one example of a geo-political factor likely to drive safe-haven flows to gold. On a 12-month horizon, we believe gold will move higher as bond yields moderate and the USD rolls over.” When considering investing in physical precious metals, investors typically go one of two routes: investing in a Gold IRA or investing in physical gold and silver bars and coins. A Gold IRA is a type of self-directed retirement account where the holder invests in physical gold instead of conventional assets such as stocks, bonds or mutual funds. It is becoming increasingly popular as a method to prepare for retirement and help protect savings. If you are seeking additional information or ready to get started, here’s what you can do: You can rollover an existing account or open a Gold IRA account with Preserve Gold, a leading U.S.-based precious metals firm. They have 0 BBB complaints – which would seem to be notable by industry standards – and excellent reviews. The company specializes in helping individuals and families diversify and protect their wealth through tangible precious metals. Preserve Gold distinguishes itself through its focus on three core principles: integrity, transparency and consistency. These principles serve as the company’s foundation for long-lasting customer relationships and reinforce the company's commitment to providing trustworthy and reliable services. To ensure a smooth and secure purchasing process, Preserve Gold offers an informed and easy way to acquire precious metals. The company's knowledgeable team assists clients in making educated purchasing decisions while prioritizing security and ease of transaction. If you’re someone who is considering investing in gold, adding a Gold IRA to your retirement portfolio can prove to be a valuable asset. It presents a range of advantages that not only help to keep your savings afloat but could also contribute to its growth in the long run. When deciding to invest in a Gold IRA, having a trusted partner like Preserve Gold can be key to achieving your financial goals. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

October 13, 2023 09:15 AM Eastern Daylight Time

Article thumbnail News Release

Tiziana to Announce Six-Month Human Safety and Biomarker Data at the ECTRIMS Annual Congress, Following-Up from Positive Outcomes Data Presented in June

Benzinga

By Rachael Green, Benzinga Tiziana (Nasdaq: TLSA) is following-up with anticipated human data and announced the acceptance of a late-breaking poster at the 39th Congress of the European Committee for Treatment and Research of Multiple Sclerosis ( ECTRIMS ) being held in Milan, Italy, October 11-13, 2023. The company will present a poster titled, “Treatment Of Six Non-Active Secondary Progressive MS With Nasal Anti-CD3 Monoclonal Antibody (Foralumab): Safety, Biomarker, And Disability Outcomes”, which is a follow-up from the positive data presented in June on 5 out of 6 patients. The key takeaway is that Tiziana’s research through its FDA authorized Expanded Access program has shown continued improvement in SPMS patients over time treated with foralumab, the Company’s intranasally administered anti-CD3 monoclonal antibody. In June, Tiziana announced a reduction in microglial activation as seen in 3-month Positron Emission Tomography (PET) scans in a total of 5 of 6 patients treated. The safety and biomarker data presented at ECTRIMS will include a clinical update on all 6 patients and will include six-month of follow-up with a PET scan. Activated microglia are believed to play a prominent role in the pathogenesis of neuroinflammatory diseases including multiple sclerosis, Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). A reduction in microglial activation is associated with lowered inflammation in the brain. Inflammation in the brain drives the disease pathology in multiple sclerosis. In SPMS, inflammation in the brain occurs in microglia, the brain’s immune cells, which drive the neurodegeneration of brain cells. During the inflammatory process associated with SPMS, microglia are involved in the destruction of myelin, the protective sheath covering of nerve fibers, and contribute to the formation of MS lesions. The Company announced in September advancing site selection for the SPMS phase 2a trial, which will have up to ten new clinical sites across the US. The news followed an Investigator's Meeting with principal investigators at Brigham and Women's Hospital, a founding member of Mass General Brigham Healthcare System, to begin site initiation. Matthew W. Davis, M.D., RPh, Chief Operating Officer and Chief Medical Officer of Tiziana Life Sciences, stated in the press release, "As planned for this quarter, we are on track and have begun site initiation visits so patient enrollment begins in this critical clinical trial. Advancing our lead anti-CD3 therapeutic, foralumab, in na-SPMS into Phase 2a will enable Tiziana to define novel endpoints, such as PET imaging, a similar target endpoint in our Expanded Access program (EAP). We are encouraged as five out of six patients in our open-label EAP have improved by qualitative analysis in their PET scans (3 months of treatment) compared to baseline. Phase 2a na-SPMS study assesses the same outcome measure, but now, and for the first time for this novel therapeutic, in a double-blind, randomized placebo control, a multi-center trial is now underway.” This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

October 13, 2023 09:15 AM Eastern Daylight Time

1 ... 195196197198199 ... 644